StonvexLoading…
StonvexStonvexStonvexCore line items from EPRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
Operating Income | $-38.59M | $-25.74M | $-28.93M |
Net Income | $-38.58M | $-25.50M | $-28.22M |
EPS (Diluted) | $-1.03 | $-0.76 | $-1.17 |
Total Assets | $86.15M | $34.94M | $20.27M |
Total Liabilities | $5.70M | $3.10M | $19.37M |
Cash & Equivalents | $80.56M | $33.10M | $19.34M |
Free Cash Flow OCF − CapEx | $-29.14M | $-30.10M | $-20.82M |
Shares Outstanding | 51.94M | 35.64M | 27.28M |